Trust Point’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Trust Point's VRTX Position: Q3 2026 in Review
Trust Point increased its Vertex Pharmaceuticals (VRTX) stake by 86% in Q3 2026, buying an estimated $348K and bringing the position to 1,472 shares worth $770K. The position accounts for 0.06% of the portfolio, ranked #173.
Trust Point first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Trust Point held 1,472 shares of Vertex Pharmaceuticals worth $770K as of Q3 2026.
- Trust Point bought 679 Vertex Pharmaceuticals shares in Q3 2026, an estimated $348K.
- Vertex Pharmaceuticals made up 0.06% of Trust Point's portfolio in Q3 2026, its #173 holding.
- Trust Point first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.